These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20517160)

  • 1. Potent in vitro inactivation of both free and cell-associated CCR5- and CXCR4-tropic HIV-1 by common commercial soap bars from South Africa.
    Jenabian MA; Auvert B; Saïdi H; Lissouba P; Matta M; Bélec L
    J Acquir Immune Defic Syndr; 2010 Aug; 54(4):340-2. PubMed ID: 20517160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of CXCR4-tropic HIV-1 infection by lipopolysaccharide: evidence of different mechanisms in macrophages and T lymphocytes.
    Verani A; Sironi F; Siccardi AG; Lusso P; Vercelli D
    J Immunol; 2002 Jun; 168(12):6388-95. PubMed ID: 12055257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV co-receptors as targets for antiviral therapy.
    Schols D
    Curr Top Med Chem; 2004; 4(9):883-93. PubMed ID: 15134547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokine receptor-directed agents as novel anti-HIV-1 therapies.
    Mills SG; DeMartino JA
    Curr Top Med Chem; 2004; 4(10):1017-33. PubMed ID: 15193136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCR4 and CCR5 on human thymocytes: biological function and role in HIV-1 infection.
    Zaitseva MB; Lee S; Rabin RL; Tiffany HL; Farber JM; Peden KW; Murphy PM; Golding H
    J Immunol; 1998 Sep; 161(6):3103-13. PubMed ID: 9743377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of HIV infection by CXCR4 and CCR5 chemokine receptor antagonists.
    De Clercq E; Schols D
    Antivir Chem Chemother; 2001; 12 Suppl 1():19-31. PubMed ID: 11594685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 coreceptors and their inhibitors.
    Ray N; Doms RW
    Curr Top Microbiol Immunol; 2006; 303():97-120. PubMed ID: 16570858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial inactivation of CCR5- and CXCR4- tropic HIV-1 by human urine.
    Auvert B; Jenabian MA; Saidi H; Lissouba P; Bélec L
    Arch Virol; 2011 Dec; 156(12):2181-6. PubMed ID: 21947506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV chemokine receptor inhibitors as novel anti-HIV drugs.
    Princen K; Schols D
    Cytokine Growth Factor Rev; 2005 Dec; 16(6):659-77. PubMed ID: 16005254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing chemokine co-receptor usage in HIV.
    Coakley E; Petropoulos CJ; Whitcomb JM
    Curr Opin Infect Dis; 2005 Feb; 18(1):9-15. PubMed ID: 15647694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of CXCR4 tropism and CCR5-tropic resistance in treatment-experienced participants receiving maraviroc in the 48-week MOTIVATE 1 and 2 trials.
    Jubb B; Lewis M; McFadyen L; Simpson P; Mori J; Chan P; Weatherley B; van der Ryst E; Westby M; Craig C
    Antivir Chem Chemother; 2019; 27():2040206619895706. PubMed ID: 31856576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tropism switch in patients infected with HIV-1 and its clinical implications for the treatment with CCR5-receptor inhibitors.
    Arastéh K; Stocker H
    Eur J Med Res; 2007 Oct; 12(9):397-402. PubMed ID: 17933720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penicillixanthone A, a marine-derived dual-coreceptor antagonist as anti-HIV-1 agent.
    Tan S; Yang B; Liu J; Xun T; Liu Y; Zhou X
    Nat Prod Res; 2019 May; 33(10):1467-1471. PubMed ID: 29258357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of CCR5- but not CXCR4-tropic HIV-1 in lymphoid tissue by human herpesvirus 6.
    Grivel JC; Ito Y; Fagà G; Santoro F; Shaheen F; Malnati MS; Fitzgerald W; Lusso P; Margolis L
    Nat Med; 2001 Nov; 7(11):1232-5. PubMed ID: 11689888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytolytic nanoparticles attenuate HIV-1 infectivity.
    Hood JL; Jallouk AP; Campbell N; Ratner L; Wickline SA
    Antivir Ther; 2013; 18(1):95-103. PubMed ID: 22954649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains.
    Huang L; Bosch I; Hofmann W; Sodroski J; Pardee AB
    J Virol; 1998 Nov; 72(11):8952-60. PubMed ID: 9765440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCR4-tropic HIV-1 suppresses replication of CCR5-tropic HIV-1 in human lymphoid tissue by selective induction of CC-chemokines.
    Ito Y; Grivel JC; Chen S; Kiselyeva Y; Reichelderfer P; Margolis L
    J Infect Dis; 2004 Feb; 189(3):506-14. PubMed ID: 14745709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of HIV-1 coreceptor tropism in clinical practise.
    Foeglein A; Walter H
    Eur J Med Res; 2007 Oct; 12(9):473-82. PubMed ID: 17933729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the thymus in HIV infection: a 10 year perspective.
    Ho Tsong Fang R; Colantonio AD; Uittenbogaart CH
    AIDS; 2008 Jan; 22(2):171-84. PubMed ID: 18097219
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
    Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
    AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.